Virbac SA

Paris Stock Exchange VIRP.PA

Virbac SA Total Non-Current Liabilities for the year ending December 31, 2023: USD 161.99 M

Virbac SA Total Non-Current Liabilities is USD 161.99 M for the year ending December 31, 2023, a 15.95% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

Virbac SA Total Non-Current Liabilities for the year ending December 31, 2022 was USD 139.71 M, a -4.18% change year over year.
Virbac SA Total Non-Current Liabilities for the year ending December 31, 2021 was USD 145.81 M, a -16.29% change year over year.
Virbac SA Total Non-Current Liabilities for the year ending December 31, 2020 was USD 174.19 M, a -49.42% change year over year.
Virbac SA Total Non-Current Liabilities for the year ending December 31, 2019 was USD 344.37 M, a -19.61% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

Paris Stock Exchange: VIRP.PA

Virbac SA

CEO	Mr. Habib Ramdani
IPO Date	July 7, 1992
Location	France
Headquarters	13e rue LID - BP 27
Employees	5,459
Sector	Consumers Staples
Industries Pet Food Agriculture Cosmetics Personal Care Pharmaceuticals

Description

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Key trends

Past 5 years